| 12233108 |
Compositions and methods for promoting islet viability and enhancing insulin secretion |
Gordon W. Laurie, Kenneth Brayman, Preeti Chhabra, Mingyang Ma, Karina Teixeira |
2025-02-25 |
|
| 12214079 |
Micronized lipids |
— |
2025-02-04 |
|
| 12214080 |
Micronized lipids |
— |
2025-02-04 |
|
| 12064469 |
Stable peptide compositions |
Gordon W. Laurie, Marc G. Odrich, Michelle Carpenter, Paul A. Laskar |
2024-08-20 |
|
| 11028077 |
Crystalline pharmaceutical and methods of preparation and use thereof |
John Burnier, Frederic Naud |
2021-06-08 |
$23,526,000 |
| 10960087 |
Compositions and methods for treatment of diabetic retinopathy |
John Burnier, Charles Semba |
2021-03-30 |
$110,497,000 |
| 10188641 |
Compositions and methods for treatment |
John Burnier |
2019-01-29 |
|
| 9447077 |
Crystalline pharmaceutical and methods of preparation and use thereof |
John Burnier, Frederic Naud |
2016-09-20 |
|
| 9045457 |
Compositions and methods for treatment |
John Burnier, Min Zhong, Wang Shen, Johan D. Oslob, Kenneth J. Barr |
2015-06-02 |
|
| 8871935 |
Crystalline pharmaceutical and methods of preparation and use thereof |
John Burnier, Frederic Naud |
2014-10-28 |
|
| 8592450 |
Compositions and methods for treatment of eye disorders |
John Burnier |
2013-11-26 |
|
| 8367701 |
Crystalline pharmaceutical and methods of preparation and use thereof |
John Burnier, Frederic Naud |
2013-02-05 |
|
| 8168655 |
Compositions and methods for treatment of eye disorders |
John Burnier |
2012-05-01 |
|
| 8080562 |
Crystalline pharmaceutical and methods of preparation and use thereof |
John Burnier, Frederic Naud |
2011-12-20 |
|
| 7348333 |
Cycloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
Volkmar Wehner, Jochen Knolle, Hans Ulrich Stilz, Jean-Francois Gourvest, Denis Carniato +3 more |
2008-03-25 |
|
| 7259159 |
Guanidino derivatives as inhibitors of cell adhesion |
Anuschirwan Peyman, David William Will, Robert McDowell, Jean-Francois Gourvest, Jean-Marie Ruxer +1 more |
2007-08-21 |
$85,560,000 |
| 6872735 |
LFA-1 antagonist compounds |
Daniel J. Burdick, Mark S. Stanley, David A. Oare, Mark E. Reynolds, James Marsters |
2005-03-29 |
$605,833,000 |
| 6867208 |
Vitronectin receptor antagonists, their preparation and their use |
Volkmar Wehner, Hans Ulrich Stilz, Anuschirwan Peyman, Jochen Knolle, Jean-Marie Ruxer +3 more |
2005-03-15 |
$276,278,000 |
| 6867213 |
(2S)-2-(adamantan-1-ylmethoxycarbonylamino)-3-(4-(2-(1,4,5,6-tetrhydropyrimidin-2-ylcarbamoyl)ethyl)benzoylamino)propionic acid isopropyl ester, its preparation and its use |
Anuschirwan Peyman, Theodor Wollmann, Gerhard Brejpohl, Jean-Francois Gourvest, Jean-Marie Ruxer +1 more |
2005-03-15 |
$276,278,000 |
| 6762190 |
Thienylalanine derivatives as inhibitors of cell adhesion |
Jean-Francois Gourvest, Anuschirwan Peyman, Jean-Marie Ruxer, Karl-Heinz Scheunemann |
2004-07-13 |
$193,818,000 |
| 6747148 |
Sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion |
Anuschirwan Peyman, David William Will, Jochen Knolle, Karlheinz Scheunemann, Denis Carniato +4 more |
2004-06-08 |
$168,870,000 |
| 6747016 |
Substituted purine derivatives as inhibitors of cell adhesion |
Anuschirwan Peyman, Jochen Knolle, Jean-Francois Gourvest, Jean-Marie Ruxer |
2004-06-08 |
|
| 6743800 |
Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
Anuschirvan Peyman, Karl-Heinz Scheunemann, Jean-Francois Gourvest, Jean-Marie Ruxer |
2004-06-01 |
|
| 6723727 |
Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them |
Anuschirwan Peyman, Jochen Knolle, Volkmar Wehner, Gerhard Breipohl, Jean-Francois Gourvest +1 more |
2004-04-20 |
$266,721,000 |
| 6667318 |
LFA-1 antagonist compounds |
Daniel J. Burdick, Mark S. Stanley, David A. Oare, Mark E. Reynolds, James Marsters |
2003-12-23 |
$658,778,000 |
